"The vaccine rollout was slow to start, hampered by logistical challenges, a lack of vaccine supply, and concerns about rare but serious side effects. However, it picked up pace by mid-2021 as the eastern states experienced a growing wave of infections caused by the Delta variant," found the report.
Vaccine procurement and rollout was slow, but reduced the number of deaths
October 30, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Algorae names Nasdaq pharmaceutical chairman to strengthen board
July 15, 2026 - - Australian Biotech -
Starpharma raises $32 Million to advance dendrimer cancer programs
July 15, 2026 - - Australian Biotech -
Minister recommits to keeping MS medicines on the PBS while awaiting formal advice
July 15, 2026 - - Latest News -
Budget outlook now hangs on disability savings, but what about pharmaceuticals
July 15, 2026 - - Latest News -
Australian partnership advances gene therapy for Retinitis Pigmentosa
July 15, 2026 - - Latest News -
Patients move to reclaim access agenda ahead of sector negotiations
July 15, 2026 - - Latest News -
An opportunity to become a global destination for paediatric oncology trials
July 15, 2026 - - Latest News

